X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (27) 27
index medicus (25) 25
female (19) 19
oncology (19) 19
middle aged (11) 11
adult (9) 9
chemotherapy (9) 9
male (9) 9
aged (8) 8
breast cancer (7) 7
cancer (6) 6
care and treatment (6) 6
article (5) 5
prognosis (5) 5
survival (5) 5
treatment outcome (5) 5
abridged index medicus (4) 4
health aspects (4) 4
pancreatic cancer (4) 4
retrospective studies (4) 4
risk factors (4) 4
triple negative breast neoplasms - pathology (4) 4
aged, 80 and over (3) 3
antineoplastic agents - therapeutic use (3) 3
antineoplastic combined chemotherapy protocols - therapeutic use (3) 3
carcinoma (3) 3
cell line, tumor (3) 3
diagnosis (3) 3
disease-free survival (3) 3
drug therapy (3) 3
hematology, oncology and palliative medicine (3) 3
hydroxymethylglutaryl-coa reductase inhibitors - therapeutic use (3) 3
internal ribosome entry (3) 3
neoplasm metastasis (3) 3
neoplasms - drug therapy (3) 3
original article (3) 3
pharmacology & pharmacy (3) 3
research (3) 3
risk (3) 3
statins (3) 3
survival rate (3) 3
triple-negative breast cancer (3) 3
adjuvant chemotherapy (2) 2
adolescent (2) 2
aml (2) 2
animals (2) 2
antibodies (2) 2
antibodies, monoclonal - therapeutic use (2) 2
antibodies, monoclonal, humanized - administration & dosage (2) 2
antigens (2) 2
antineoplastic agents - adverse effects (2) 2
antineoplastic agents - pharmacology (2) 2
antineoplastic combined chemotherapy protocols - adverse effects (2) 2
apoptosis (2) 2
biological tumor marker (2) 2
biomarker (2) 2
biomedicine (2) 2
biopsy (2) 2
breast neoplasms - drug therapy (2) 2
breast neoplasms - genetics (2) 2
breast neoplasms - therapy (2) 2
brentuximab vedotin (2) 2
c-myc (2) 2
cancer research (2) 2
cardiac & cardiovascular systems (2) 2
cardio-oncology (2) 2
cardiovascular (2) 2
cardiovascular diseases (2) 2
cardiovascular diseases - chemically induced (2) 2
cell differentiation (2) 2
cell proliferation (2) 2
child (2) 2
combination (2) 2
disease progression (2) 2
dosage and administration (2) 2
dysregulation (2) 2
eif4e (2) 2
follow-up studies (2) 2
fungi (2) 2
gene-expression (2) 2
genotype & phenotype (2) 2
hematology (2) 2
hmg-coa reductase (2) 2
hydroxymethylglutaryl-coa reductase inhibitors - adverse effects (2) 2
igf1r (2) 2
immunology (2) 2
internal ribosome entry sites - genetics (2) 2
kaplan-meier estimate (2) 2
mediated translation (2) 2
medicine & public health (2) 2
messenger rna translation (2) 2
monoclonal-antibody (2) 2
mortality (2) 2
multicenter (2) 2
muscular diseases - etiology (2) 2
muscular diseases - prevention & control (2) 2
neoplasm staging (2) 2
neoplasms, second primary - therapy (2) 2
neoplastic transformation (2) 2
original (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Therapeutic Advances in Hematology, ISSN 2040-6207, 8/2012, Volume 3, Issue 4, pp. 209 - 225
Antibody-based immunotherapy has become an integral part of cancer therapeutics. However, monoclonal antibodies have their limitations as identifying an... 
cAC10-vcMMAE | CD30 | antibody-drug conjugate | Hodgkin’s lymphoma | anaplastic large cell lymphoma | SGN-35 | brentuximab vedotin | CD30 targeting | Reviews
Journal Article
Translational oncology, ISSN 1936-5233, 01/2020, Volume 13, Issue 2, p. 452
Gene expression is extensively and dynamically modulated at the level of translation. How cancer cells prioritize the translation of certain mRNAs over others... 
Journal Article
Frontiers in oncology, ISSN 2234-943X, 2017, Volume 7, p. 158
Although transcript levels have been traditionally used as a surrogate measure of gene expression, it is increasingly recognized that the latter is extensively... 
Journal Article
Cancer Research, ISSN 0008-5472, 07/2016, Volume 76, Issue 14 Supplement, pp. 3037 - 3037
The internal ribosome entry site (IRES) is a feature contained within the 5-untranslated region of the mRNA which allows the efficiency with which that mRNA is... 
Journal Article
Journal Article
Journal Article
Tumor Biology, ISSN 1010-4283, 10/2016, Volume 37, Issue 10, pp. 13247 - 13264
Journal Article
Cancer Research, ISSN 0008-5472, 08/2015, Volume 75, Issue 15 Supplement, pp. 4363 - 4363
Journal Article